Clinical Trial Manager

Manchester University NHS Foundation Trust; Manchester; On-site; GBP 40,000 - 55,000; Full time

Job summary

A leading healthcare provider in the UK is seeking a Clinical Trials Manager (CTM) Early Phase Coordinator to manage a growing research portfolio. You will ensure the operational excellence and compliance of early phase clinical trials while collaborating with diverse teams to improve patient care. The ideal candidate should have experience in clinical trials management and a strong understanding of regulatory frameworks. This role offers an opportunity to shape the future of healthcare delivery in a dynamic environment.

Benefits

Professional development opportunities

Dynamic and inclusive work environment

Qualifications

• Experience in managing clinical trials and operational leadership.
• Strong understanding of regulatory requirements and research networks.
• Excellent organizational and communication skills.

Responsibilities

• Manage an established early phase research portfolio.
• Ensure compliance with regulatory frameworks and financial management.
• Collaborate with clinical and non-clinical teams to enhance patient experiences.

Job description

We are looking to recruit a Clinical Trials Manager (CTM) Early Phase Coordinator post within the Cystic Fibrosis Early Phase research team within Research and Innovation (R&I) at Manchester University NHS Foundation Trust (MFT). The role is funded by the Cystic Fibrosis Trust Clinical Trials Accelerator Platform (CTAP). CTAP is a UK-wide initiative bringing together paediatric and adult cystic fibrosis (CF) UK centres to lead in the delivery of CF clinical trials. CTAP has created a specialist sub-network of CTAP centres with expert knowledge and facilities to lead in the UK delivery of CF Early Phase Clinical Trials. This B7 CTM EPC post at MFT, is part of this expansion and we are looking for an enthusiastic and self‑motivated individual to manage an established and growing early phase research portfolio across our site and help to provide the CF community with access to early phase clinical trials.

With more advances in cystic fibrosis care and treatment than ever before, this is an exciting time for the cystic fibrosis community and a great time to join the team.

The post holder will act as professional lead for their portfolio of work. This will include strategic planning of the design, management and capacity for studies within the specialties. They will ensure that comprehensive, high quality and efficient administrative processes are in place for setting up studies, organising necessary approvals (ethics, R&D, MHRA, Research networks etc.), data management, ensuring full compliance with the regulatory framework; including financial management of study set‑up costs and income recovery in conjunction with the R&I finance team.

Manchester University NHS Foundation Trust (MFT) is the largest provider of specialist services, and our Oxford Road Campus in Manchester, the largest health academic campus in Europe - what better place to shape and develop your leadership career.

We deliver care to over 1 million patients & users each year through our 10 hospitals and extensive community services.

Our 30,000 plus strong workforce is central to our success and innovation. You will play a pivotal part in supporting our operational excellence and strategic ambitions. You'll work collaboratively with clinical and non‑clinical teams, driving improvements that enhance patient experience, staff wellbeing, and service efficiency across the Trust.

MFT offers a dynamic, inclusive environment where your leadership, ideas, and expertise are valued. You'll have access to professional development, digital tools and opportunities to contribute to transformational projects that shape the future of healthcare delivery.

We are committed to supporting your growth and wellbeing, recognising the vital role you play in our organisation's success. Join us and help shape the future of our Trust -- make a real difference to our teams, our services, and our communities, and fundamentally, our patients.